|
|
||||||||
on Human Eosinophils: I. Loss of Membrane IL-5 Receptor
on Airway Eosinophils and Increased Soluble IL-5 Receptor
in the Airway After Allergen Challenge1




* Allergy and Immunology and
Pulmonary and Critical Care Sections of Department of Medicine, and Departments of
Biomolecular Chemistry and
Pediatrics, University of Wisconsin, Madison, WI 53792; and
¶ Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905
IL-5 is a key cytokine for eosinophil maturation, recruitment,
activation, and possibly the development of inflammation in asthma.
High concentrations of IL-5 are present in the airway after Ag
challenge, but the responsiveness of airway eosinophils to IL-5 is not
well characterized. The objectives of this study were to establish,
following airway Ag challenge: 1) the expression of membrane
(m)IL-5R
on bronchoalveolar lavage (BAL) eosinophils; 2) the
responsiveness of these cells to exogenous IL-5; and 3) the presence of
soluble (s)IL-5R
in BAL fluid. To accomplish these goals, blood and
BAL eosinophils were obtained from atopic subjects 48 h after
segmental bronchoprovocation with Ag. There was a striking reduction in
mIL-5R
on airway eosinophils compared with circulating cells.
Furthermore, sIL-5R
concentrations were elevated in BAL fluid, but
steady state levels of sIL-5R
mRNA were not increased in BAL
compared with blood eosinophils. Finally, BAL eosinophils were
refractory to IL-5 for ex vivo degranulation, suggesting that the
reduction in mIL-5R
on BAL eosinophils may regulate IL-5-mediated
eosinophil functions. Together, the loss of mIL-5R
, the presence of
sIL-5R
, and the blunted functional response (degranulation) of
eosinophils to IL-5 suggest that when eosinophils are recruited to the
airway, regulation of their functions becomes IL-5 independent. These
observations provide a potential explanation for the inability of
anti-IL-5 therapy to suppress airway hyperresponsiveness to inhaled
Ag, despite a reduction in eosinophil
recruitment.
This article has been cited by other articles:
![]() |
K. L. Veraldi, B. T. Gibson, H. Yasuoka, M. M. Myerburg, E. A. Kelly, S. Balzar, N. N. Jarjour, J. M. Pilewski, S. E. Wenzel, and C. A. Feghali-Bostwick Role of Insulin-like Growth Factor Binding Protein-3 in Allergic Airway Remodeling Am. J. Respir. Crit. Care Med., October 1, 2009; 180(7): 611 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. B. Kelly, C. J. Koziol-White, K. J. Clay, L. Y. Liu, M. E. Bates, P. J. Bertics, and N. N. Jarjour Potential Contribution of IL-7 to Allergen-Induced Eosinophilic Airway Inflammation in Asthma J. Immunol., February 1, 2009; 182(3): 1404 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Johansson, E. A. B. Kelly, W. W. Busse, N. N. Jarjour, and D. F. Mosher Up-Regulation and Activation of Eosinophil Integrins in Blood and Airway after Segmental Lung Antigen Challenge J. Immunol., June 1, 2008; 180(11): 7622 - 7635. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pazdrak, T. W. Young, S. Stafford, B. Olszewska-Pazdrak, C. Straub, V. Starosta, A. Brasier, and A. Kurosky Cross-Talk between ICAM-1 and GM-CSF Receptor Signaling Modulates Eosinophil Survival and Activation J. Immunol., March 15, 2008; 180(6): 4182 - 4190. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Barthel, M. W. Johansson, D. M. McNamee, and D. F. Mosher Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma J. Leukoc. Biol., January 1, 2008; 83(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-B. Wang, I. Ghiran, K. Matthaei, and P. F. Weller Airway Eosinophils: Allergic Inflammation Recruited Professional Antigen-Presenting Cells J. Immunol., December 1, 2007; 179(11): 7585 - 7592. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Flood-Page, C. Swenson, I. Faiferman, J. Matthews, M. Williams, L. Brannick, D. Robinson, S. Wenzel, W. Busse, T. T. Hansel, et al. A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1062 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Kang, D. H. Lee, H. Seo, J. S. Park, K. H. Nam, S. Y. Shin, C.-S. Park, and I. Y. Chung Regulation of Functional Phenotypes of Cord Blood Derived Eosinophils by {gamma}-Secretase Inhibitor Am. J. Respir. Cell Mol. Biol., November 1, 2007; 37(5): 571 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Martinez-Moczygemba, D. P. Huston, and J. T. Lei JAK kinases control IL-5 receptor ubiquitination, degradation, and internalization J. Leukoc. Biol., April 1, 2007; 81(4): 1137 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Barthel, D. S. Annis, D. F. Mosher, and M. W. Johansson Differential Engagement of Modules 1 and 4 of Vascular Cell Adhesion Molecule-1 (CD106) by Integrins {alpha}4beta1 (CD49d/29) and {alpha}Mbeta2 (CD11b/18) of Eosinophils J. Biol. Chem., October 27, 2006; 281(43): 32175 - 32187. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Brooks, M. E. Bates, R. F. Vrtis, N. N. Jarjour, P. J. Bertics, and J. B. Sedgwick Urokinase-Type Plasminogen Activator Modulates Airway Eosinophil Adhesion in Asthma Am. J. Respir. Cell Mol. Biol., October 1, 2006; 35(4): 503 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Barthel, N. N. Jarjour, D. F. Mosher, and M. W. Johansson Dissection of the Hyperadhesive Phenotype of Airway Eosinophils in Asthma Am. J. Respir. Cell Mol. Biol., September 1, 2006; 35(3): 378 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Inoue, R. Kato, S. Fukuyama, A. Nonami, K. Taniguchi, K. Matsumoto, T. Nakano, M. Tsuda, M. Matsumura, M. Kubo, et al. Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness J. Exp. Med., January 3, 2005; 201(1): 73 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Stout, M. E. Bates, L. Y. Liu, N. N. Farrington, and P. J. Bertics IL-5 and Granulocyte-Macrophage Colony-Stimulating Factor Activate STAT3 and STAT5 and Promote Pim-1 and Cyclin D3 Protein Expression in Human Eosinophils J. Immunol., November 15, 2004; 173(10): 6409 - 6417. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, N. N. Jarjour, W. W. Busse, and E. A. B. Kelly Enhanced Generation of Helper T Type 1 and 2 Chemokines in Allergen-induced Asthma Am. J. Respir. Crit. Care Med., May 15, 2004; 169(10): 1118 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Bates, L. Y. Liu, S. Esnault, B. A. Stout, E. Fonkem, V. Kung, J. B. Sedgwick, E. A. B. Kelly, D. M. Bates, J. S. Malter, et al. Expression of Interleukin-5- and Granulocyte Macrophage-Colony-Stimulating Factor-Responsive Genes in Blood and Airway Eosinophils Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 736 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sergejeva, A.-K. Johansson, C. Malmhall, and J. Lotvall Allergen exposure-induced differences in CD34+ cell phenotype: relationship to eosinophilopoietic responses in different compartments Blood, February 15, 2004; 103(4): 1270 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Terada, E. A. B. Kelly, and N. N. Jarjour Increased Thrombin Activity after Allergen Challenge: A Potential Link to Airway Remodeling? Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 373 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Kay and A. Menzies-Gow Eosinophils and Interleukin-5: The Debate Continues Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1586 - 1587. [Full Text] [PDF] |
||||
![]() |
B. Gregory, A. Kirchem, S. Phipps, P. Gevaert, C. Pridgeon, S. M. Rankin, and D. S. Robinson Differential Regulation of Human Eosinophil IL-3, IL-5, and GM-CSF Receptor {alpha}-Chain Expression by Cytokines: IL-3, IL-5, and GM-CSF Down-Regulate IL-5 Receptor {alpha} Expression with Loss of IL-5 Responsiveness, but Up-Regulate IL-3 Receptor {alpha} Expression J. Immunol., June 1, 2003; 170(11): 5359 - 5366. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. Liu, J. B. Sedgwick, M. E. Bates, R. F. Vrtis, J. E. Gern, H. Kita, N. N. Jarjour, W. W. Busse, and E. A. B. Kelly Decreased Expression of Membrane IL-5 Receptor {alpha} on Human Eosinophils: II. IL-5 Down-Modulates Its Receptor Via a Proteinase-Mediated Process J. Immunol., December 1, 2002; 169(11): 6459 - 6466. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |